HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $18 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating on Instil Bio (NASDAQ:TIL), maintaining an $18 price target.

May 13, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Instil Bio receives a reiterated Buy rating and an $18 price target from HC Wainwright & Co., indicating strong analyst confidence.
Analyst ratings, especially from reputable firms like HC Wainwright & Co., can significantly influence investor sentiment and stock prices. A reiterated Buy rating and a maintained price target suggest a positive outlook for Instil Bio, potentially leading to increased investor interest and a positive short-term price movement.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100